Having problems reading this email? View it in your browser >>
|
||
|
||
HIV and the ageing processMany people ask whether HIV speeds up the ageing process. In other words, do people living with HIV have a decline in physical function and develop age-related conditions at younger ages than their peers? There is still a lot that we don’t know about this, but a new study adds some interesting data. The researchers wanted to compare ‘chronological age’ (the number of years a person has lived) with ‘biological age’. There is no agreed definition of biological age but the researchers tried to measure this by using a set of ten biomarkers. A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a body process, a condition or a disease. In this case, the ten biomarkers all reflect age-related changes in body function or composition. They looked at three groups of people:
One reason for the greater biological ageing of people with HIV in this study is likely to be viral infections and lifestyle factors (which would be similar in the first and second groups). But despite those living with HIV currently having an undetectable viral load, they seem to have a more advanced biological age than their HIV-negative peers. It’s likely that some of this is due to damage to the immune system in previous years. The researchers also found that one particular anti-HIV medication – the protease inhibitor saquinavir which was mostly used in the 1990s – was associated with increased ageing. But they were surprised to find that other older anti-HIV drugs were not linked with ageing in their data. For more information, read NAM's factsheet 'HIV and the ageing process'. Laws on non-disclosure of HIV statusAround the world, many countries continue to oblige a person living with HIV to disclose their status to a sexual partner before sex, regardless of the risk of HIV transmission or the protective measures taken. In these jurisdictions, HIV transmission does not need to occur: a person can be prosecuted for exposure (putting another person at risk of HIV) in the absence of transmission. Moreover, the law in many countries has not kept up with the scientific knowledge that people who have an undetectable viral load are uninfectious and pose no risk to their sexual partners. Two new studies have looked at the impact of such laws on people living with HIV in Canada and Sweden. The Canadian researchers focused on women, especially Indigenous women. It was important for minority women to be oversampled as the prevalence of both HIV and prosecutions is higher in Indigenous people. The study showed that women were largely unfamiliar with and poorly informed about laws pertaining to non-disclosure. They felt that they were under surveillance by the criminal justice system when it came to their sex lives, as this woman explained: “So how many people do you have in that room? You have the lawyer that’s witnessing the paper that you’re signing that you’ve disclosed. You have the doctor to say, ‘Yeah, you’re under a viral load’. You’ve got the forensic scientist there getting any evidence. You know, everybody is watching.” Women asked how they could be expected to prove that they had disclosed their status: “Okay, so say I had a sexual partner. I just met this guy. And my CD4 count is 880. I’m undetectable. But I’ve got to tell him before we get into bed. Do I need to make him sign a document and lock it up and have it witnessed by the neighbour?” Women said that if there was conflict in a relationship, a partner or ex-partner could threaten to report them to the police as not having disclosed their status. They pointed out that the law requires women to disclose their status in all kinds of situations – even to an abusive partner or a rapist. The non-disclosure law therefore put women in a more vulnerable position and at greater risk for violence. In Sweden, doctors are obliged to give people living with HIV written ‘rules of conduct’. These outline the patient’s obligations, including disclosure of HIV status to sexual partners and using condoms. Since 2013, doctors can give an ‘exemption’ to people with an undetectable viral load from disclosing their status to sexual partners, but the researchers found that not all the gay men living with HIV they interviewed had been told about this. Many described being given the ‘rules of conduct’ as an inherently stigmatising and negative experience, with a sense of being treated like a criminal. They also complained that they were given different messages by different doctors and nurses, with some clinicians appearing to be reluctant to explain that “undetectable equals untransmittable” (U=U). The implied message was that men should continue using condoms as a precaution. One man said: “After multiple ifs and buts [the nurse] finally explained the thing with low infectiousness. I recently thought about this and it was very moralising. “Well, don’t forget that there is still a risk of transmission”. All I really wanted was a clear answer. But she hardly wanted to give me that information.” Men had often found out this information for themselves from other people living with HIV, HIV organisations or academic literature. Finding this out provided a relief from anxiety. “There was a security within myself that the virus cannot be transmitted, and reasonably I should be able to have sex on equal terms, as if I didn’t have the virus.” For information on the law in England and Wales, read NAM’s illustrated leaflet ‘Transmission and the law.’ For more information on the law in Scotland, read a leaflet produced by Terrence Higgins Trust, National AIDS Trust and HIV Scotland, ‘Prosecutions for HIV & STI transmission or exposure - a guide for people living with HIV in Scotland’. Fatty liver diseaseNon-alcoholic fatty liver disease occurs when fat accumulates in liver cells, in people who do not drink heavily. In some people fat accumulation will cause no symptoms but in a minority of people, fat accumulation leads to more serious liver damage in the form of non-alcoholic steatohepatitis, fibrosis or cirrhosis, resulting in declining liver function. Liver fat build-up is linked to being overweight and having a cluster of metabolic problems like high blood fat levels and type 2 diabetes (known as metabolic syndrome). Losing weight, regular exercise and a balanced diet can lower your risk of developing fatty liver disease. It’s possible that immune activation caused by HIV and a history of treatment with the first generation of antiretroviral drugs may place people living with HIV at higher risk of fatty liver disease. For more information read NAM's factsheet 'Fatty liver disease and HIV'. Editors' picks from other sourcesTrump announces goal of ending HIV/AIDS epidemic by end of next decadefrom Washington Post The president who fired his HIV/AIDS advisory council a year ago and has no one working in the Office of National AIDS Policy pivoted on Tuesday night, pledging to focus fresh money and knowledge to eradicate the epidemic. What's going on with the NHS PrEP trial in England?from Vice NHS England delayed plans to fund doubling the trial in size, just days after its announcement – and that may leave people at even greater risk. 'It's very traumatic': HIV-positive individuals anxious, frustrated after MOH data leakfrom Channel NewsAsia Singapore's Ministry of Health (MOH) revealed that the confidential information of these individuals was illegally leaked online.The information includes names, identification and phone numbers, addresses, HIV test results and medical information. For our stable HIV patients, why are we still sending all these lab tests so often?from NEJM Journal Watch Do the guidelines for laboratory monitoring still make sense when our HIV treatments have become so safe and effective? With the chemsex scene booming, are gay men using drugs to medicate complex issues around sex?from Medium Experts say many men have a ‘sex problem’ and are using drugs as the solution. Traditional treatment methods may not be enough. | ||
Connect with us |
||
aidsmap is an award-winning, community-based organisation, which works from the UK. We deliver reliable and accurate HIV information across the world to HIV-positive people and to the professionals who treat, support and care for them.
NAM Publications
Cally Yard, 439 Caledonian Road, London N7 9BG Company limited by guarantee. Registered in England & Wales, number: 2707596 Registered charity, number: 1011220 To unsubscribe please click here Privacy Policy: www.aidsmap.com/about-us/confidentiality |